FORM SC 13D

Company

ADC Therapeutics SA

Filed

September 14, 2020

Accession Number

0000950103-20-017858

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →